Insulin independence after conversion to tacrolimus and sirolimus-based immunosuppression in islet-kidney recipients [3]

Transplantation

Volumn 76, Issue 7, 2003, Pages 1133-1134

  Toso, Christian ^a,c   Morel, Philippe ^a   Bucher, Pascal ^a   Mathe, Zoltan ^a   Demuylder Mischler, Sandrine ^a   Bosco, Domenico ^a   Berney, Thierry ^a   Oberholzer, José ^a,b   Shapiro, James ^b   Philippe, Jacques ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DACLIZUMAB; GLUCOCORTICOID; INSULIN; MYCOPHENOLIC ACID; PREDNISONE; RAPAMYCIN; TACROLIMUS;

ADULT; CASE REPORT; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN TREATMENT; KIDNEY FUNCTION; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; LETTER; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; RECIPIENT;

ADULT; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; IMMUNOSUPPRESSIVE AGENTS; INSULIN; ISLETS OF LANGERHANS TRANSPLANTATION; KIDNEY TRANSPLANTATION; SIROLIMUS; TACROLIMUS;

EID: 17144470779     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000090394.71832.E5     Document Type: Letter

References (3)

1. Ryan EA, Lakey JR, Paty BW, et al. Successful islet transplantation: continued insulin reserve provides long-term glycemic control. Diabetes 2002; 5: 2148.
2. Oberholzer J, Triponez F, Mage R, et al. Human islet transplantation: lessons from 13 autologous and 13 allogeneic transplantations. Transplantation 2000; 69: 1115.
3. Benhamou PY, Oberholzer J, Toso C, et al. Human islet transplantation network for the treatment of type I diabetes: first data from the Swiss-French GRAGIL consortium (1999-2000). Groupe de Recherche Rhin Rhjne Alpes Geneve pour la transplantation d'Ilots de Langerhans. Diabetologia 2001; 44: 859.